IMMIX BIOPHARMA INC COM

IMMIX BIOPHARMA INC COM is a security (CUSIP 45258H106) tracked across SEC portfolio filings. 82 institutional managers reported $235.5M on Form 13F as of 2026-06-30; 6 registered fund positions totaling $7.7M via N-PORT as of 2026-03-31.

Summary

Top institutional holders (Form 13F)

Showing 15 of 82 managers by value.

ManagerLocationValueShares
JANUS HENDERSON GROUP PLCLONDON, X0$43.7M4,802,002
Saturn V Capital Management LPAUSTIN, TX$33.6M3,693,585
EVENTIDE ASSET MANAGEMENT, LLCBoston, MA$23.2M2,549,019
MILLENNIUM MANAGEMENT LLCNEW YORK, NY$15.9M1,750,200
MARSHALL WACE, LLPLONDON, X0$15.0M1,641,552
Logos Global Management LPSan Francisco, CA$11.2M1,225,000
Bleichroeder LPNEW YORK, NY$9.1M1,000,000
FRANKLIN RESOURCES INCSan Mateo, CA$8.8M969,066
Velan Capital Investment Management LPAlpharetta, GA$6.7M740,000
VANGUARD GROUP INCValley Forge, PA$5.7M1,095,814
SUSQUEHANNA INTERNATIONAL GROUP, LLPBALA CYNWYD, PA$5.4M471,394
Blue Owl Capital Holdings LPNew York, NY$5.0M547,552
BlackRock, Inc.New York, NY$4.3M468,377
GEODE CAPITAL MANAGEMENT, LLCBOSTON, MA$4.2M463,384
LGT Fund Management Co Ltd.VADUZ, N2$3.8M416,594

Top fund holders (N-PORT)

FundRegistrantValue% of fund
VANGUARD EXTENDED MARKET INDEX FUNDVANGUARD INDEX FUNDS$4.2M0.51%
T. Rowe Price Health Sciences Fund, Inc.T. ROWE PRICE HEALTH SCIENCES FUND, INC.$3.0M2.73%
VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUNDVANGUARD INSTITUTIONAL INDEX FUNDS$208K0.07%
VANGUARD BALANCED INDEX FUNDVANGUARD VALLEY FORGE FUNDS$206K0.03%
T. Rowe Price Health Sciences PortfolioT. ROWE PRICE EQUITY SERIES, INC.$182K2.75%
Blackstone Alternative Multi-Strategy FundBlackstone Alternative Investment Funds$-911-0.00%

More